The molecule and its design
Retatrutide behaves the way it does because of how it is built.
Engineering one peptide to speak three hormonal languages
Retatrutide behaves the way it does because of how it is built. It is a single engineered peptide that activates three receptors at once, GIP, GLP-1 and glucagon, which are closely enough related that one chain can reach all three. Getting the balance between them right is a hard chemistry problem, and it is the reason a triple agonist took so long to reach the clinic.
This unit walks through what the published record actually says about the molecule: a 39-amino-acid peptide engineered from a GIP backbone, acylated with a fatty diacid chain that enables binding to albumin, a blood protein, a half-life of about six days, and a receptor profile tilted sharply toward GIP.
Key terms
One engineered peptide
Retatrutide is not a natural hormone. It is an engineered peptide, described by its sponsor as an acylated peptide suitable for weekly injection and by the liver paper as a single protein conjugated to a fatty diacid moiety (a fat-derived chemical group) that activates the human GIP, GLP-1 and GCG receptors. The discovery paper gives the build: a single peptide of 39 amino acids (its building blocks, also called residues), engineered from a GIP peptide backbone (the chain of the natural hormone GIP, used as the template). The diagram below is a schematic of the two parts that description names, a receptor-activating peptide and an attached lipid chain, not an atomic structure.
Read left to right, the core description is simple: a peptide that switches on three receptors, conjugated to a fatty diacid chain that enables albumin binding, with a half-life of about six days. The next pages take the two consequences that matter most in practice, the weekly rhythm and the receptor balance.
AdvancedWhat the discovery paper says about the build
The discovery paper spells out the chemistry. Retatrutide is a 39-amino-acid single peptide engineered from a GIP backbone, with three non-coded amino acids (ones the genetic code does not specify) at positions 2, 13 and 20. The one at position 2, an amino acid called Aib, gives stability against cleavage by the enzyme DPP-4 (dipeptidyl-peptidase 4), and a C20 fatty diacid joined at the lysine in position 17 enables albumin binding to extend the half-life. The behaviour that results is 8.9 times the potency of native GIP at the GIP receptor, about 0.3 and 0.4 times the natural hormone at the glucagon and GLP-1 receptors, and a half-life near six days.